Skip to main content
David Vanderweele, MD, Oncology, Chicago, IL

DavidJVanderweeleMDPhD

Oncology Chicago, IL

Genitourinary Oncology, Hematologic Oncology

Associate Professor, Hematology and Oncology, Northwestern University Feinberg School of Medicine

Dr. Vanderweele is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Vanderweele's full profile

Already have an account?

  • Office

    251 E Huron St
    Chicago, IL 60611

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 2009 - 2012
  • University of Chicago
    University of ChicagoResidency, Internal Medicine, 2007 - 2009
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2007

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2009 - 2026
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Lectures

  • Neoadjuvant androgen deprivation therapy and enzalutamide: Imaging and pathological responses. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Combination Treatment Extends Survival in Advanced Bladder Cancer
    Combination Treatment Extends Survival in Advanced Bladder CancerSeptember 17th, 2024
  • Combination Treatment Extends Survival in Locally Advanced Bladder Cancer
    Combination Treatment Extends Survival in Locally Advanced Bladder CancerSeptember 15th, 2024